Boston Scientific Corporation Stock price

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2024-03-18 pm EDT 5-day change 1st Jan Change
67.24 USD +1.52% Intraday chart for Boston Scientific Corporation +1.69% +16.31%
Sales 2024 * 15.56B Sales 2025 * 16.99B Capitalization 98.65B
Net income 2024 * 2.06B Net income 2025 * 2.58B EV / Sales 2024 * 6.71 x
Net Debt 2024 * 5.69B Net Debt 2025 * 2.55B EV / Sales 2025 * 5.95 x
P/E ratio 2024 *
48.4 x
P/E ratio 2025 *
39.6 x
Employees 48,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.46%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.52%
1 week+1.69%
Current month+1.56%
1 month+2.16%
3 months+21.13%
6 months+26.87%
Current year+16.31%
More quotes
1 week
65.52
Extreme 65.52
67.60
1 month
65.34
Extreme 65.335
68.07
Current year
57.11
Extreme 57.11
68.07
1 year
47.52
Extreme 47.515
68.07
3 years
34.98
Extreme 34.98
68.07
5 years
24.10
Extreme 24.1
68.07
10 years
11.10
Extreme 11.1
68.07
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 11-10-16
Director of Finance/CFO 58 96-11-30
Chief Tech/Sci/R&D Officer - 09-08-31
Members of the board TitleAgeSince
Director/Board Member 61 21-06-22
Director/Board Member 69 15-03-31
Director/Board Member 72 14-02-28
More insiders
Date Price Change Volume
24-03-18 67.24 +1.52% 5,833,683
24-03-15 66.23 -0.94% 8,850,950
24-03-14 66.86 +1.24% 7,327,729
24-03-13 66.04 -2.15% 9,236,134
24-03-12 67.49 +2.07% 6,462,540

Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT

More quotes
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (61.5%): products used in cardiology surgeries (28.4% of net sales), cardiac rhythm management (26.8%), peripheral surgeries (24.2%), electrophysiology tests (7.5%) and other (13.1%); - endodontic surgery (31.3%): equipment used in endoscopy (55.6% of net sales) and urology (44.4%); - neuromodulation (7.2%). The United States account for 60.2% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
67.24 USD
Average target price
71.47 USD
Spread / Average Target
+6.30%
Consensus
  1. Stock
  2. Equities
  3. Stock Boston Scientific Corporation - Nyse